MedtechLedger currently links 40 FDA records to the applicant name Biotronik, Inc.. It includes 5 original PMA approvals. 19 entries are PMA supplements. 16 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Oct 11, 1996 to Oct 28, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Changes described in PMA records
FDA posted a 30-day notice for supplement S300 to PMA P950037, dated 2026-10-28, with decision OK30. The stated purpose is to implement updates to the final acceptance testing workflow for the Amvia/Solvia family of pacemakers and CRT-Ps. The supplement reason is recorded as a process change involving manufacturer, sterilizer, packager, or supplier.
The affected devices include Amvia Sky DR-T, Amvia Sky SR-T, Amvia Edge DR-T, Amvia Edge SR-T, Solvia Rise DR-T, Solvia Rise SR-T, and Amvia Sky HF-T QP. The source statement does not describe the specific acceptance-testing changes, the manufacturing site, or any effect on device labeling or performance. A supplement of this type is not a new approval of the whole system.
FDA approval-order wording
to implement updates to the final acceptance testing workflow for the Amvia/Solvia family of pacemakers and CRT-Ps
Oct 28, 2026 · 30-Day NoticeBiotronik, Inc. holds PMA P980023/S153, a 30-Day Notice recorded with decision OK30 on 2026-10-22. The supplement covers a process change attributed to manufacturer, sterilizer, packager or supplier, described as updating visual and dimensional incoming inspection testing for certain components and raw materials used in IPG, ICD and lead manufacturing. The listed products include Ilivia Neo and Intica Neo VRT DX, Acticor Sky VR-T, Rivacor Sky and Rivacor Rise VR-T devices, categorized as non-CRT implantable cardioverter defibrillators under product code LWS, Cardiovascular specialty.
The record does not identify which components or raw materials are affected, what the prior inspection criteria were, or the revised acceptance limits, so the operational effect on manufacturing cannot be assessed from this entry. OK30 is the recorded decision for this supplement; it is not a new approval of the underlying system, and no clinical, efficacy or patient-selection conclusions follow from the notice. The title field is truncated in the source, leaving the full device list unknown.
Whether the revised inspection changes defect detection or supply risk for these ICDs and leads is not stated in the available data.
FDA approval-order wording
updating visual and dimensional incoming inspection testing for certain components and raw materials used in IPG, ICD, and lead manufacturing
Oct 22, 2026 · 30-Day NoticeFDA database entry P000009/S135 records a 30-Day Notice for Biotronik, Inc. The stated purpose is updating visual and dimensional incoming inspection testing for certain components and raw materials used in IPG, ICD, and lead manufacturing. The listed device names include Ilivia Neo 7 DRT, Intica Neo 7 DRT, Intica Neo 5 DRT, Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, and Rivacor Aur, under product code MRM for a dual-chamber implantable defibrillator.
The supplement reason is a process change involving manufacturer, sterilizer, packager, or supplier. The entry does not state which specific components or raw materials are affected, what dimensional or visual criteria changed, or whether any acceptance limits were revised. It also does not provide evidence of safety or clinical effectiveness. This supplement does not constitute a new approval of the original PMA system.
FDA approval-order wording
updating visual and dimensional incoming inspection testing for certain components and raw materials used in IPG, ICD, and lead manufacturing
Oct 22, 2026 · 30-Day NoticeThe FDA record for P950037/S299 describes a 30-day notice filed by Biotronik, Inc. under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The stated change is "updating visual and dimensional incoming inspection testing for certain components and raw materials used in IPG, ICD, and lead manufacturing." In plain terms, incoming inspection for selected components and raw materials used in implantable pulse generator, implantable cardioverter defibrillator, and lead production is being revised on visual and dimensional criteria. The notice does not specify which components or raw materials, what the prior testing was, what replaces it, or the acceptance criteria.
The identifier ties this to PMA P950037, a supplement numbered S299, so the action amends the existing approval rather than constituting a new approval of the whole system. The device category is implantable pacemaker pulse-generator, product code DXY, cardiovascular specialty, with decision OK30 dated 2026-10-22. The stated purpose concerns inspection testing only; the record offers no independent evidence on safety, clinical effectiveness, or any change in indications, and it should not be read as such.
FDA approval-order wording
updating visual and dimensional incoming inspection testing for certain components and raw materials used in IPG, ICD, and lead manufacturing
Oct 22, 2026 · 30-Day NoticeThis 30-day notice for PMA supplement P070008/S184 reports a change to incoming inspection procedures at Biotronik, Inc. The stated purpose is updating visual and dimensional incoming inspection testing for certain components and raw materials used in IPG, ICD, and lead manufacturing. The affected device category is an implantable pulse generator with cardiac resynchronization (CRT-P), product code NKE.
The notice does not describe a new approval of the device system, a new indication, or clinical data. It is a process change involving manufacturer, sterilizer, packager, or supplier. The source statement does not specify which components or raw materials are affected, what dimensional tolerances changed, or how the updated testing relates to finished device performance.
FDA approval-order wording
updating visual and dimensional incoming inspection testing for certain components and raw materials used in IPG, ICD, and lead manufacturing
Oct 22, 2026 · 30-Day NoticeSubsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.